We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$240M
AUM Growth
+$31.8M
Cap. Flow
+$17.7M
Cap. Flow %
7.4%
Top 10 Hldgs %
80.41%
Holding
94
New
15
Increased
22
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.06M
2
HHH icon
Howard Hughes
HHH
+$1.86M
3
DAL icon
Delta Air Lines
DAL
+$1.2M
4
DD icon
DuPont de Nemours
DD
+$1.13M
5
AB icon
AllianceBernstein
AB
+$1.08M

Sector Composition

Rank Sector Weight
1 Healthcare 73.39%
2 Financials 8.14%
3 Technology 3.76%
4 Real Estate 3.58%
5 Industrials 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$646B
$963K 0.4%
7,280
CNQ icon
27
Canadian Natural Resources
CNQ
$101B
$933K 0.39%
+66,059
New +$994K
ENFC
28
DELISTED
Entegra Financial Corp.
ENFC
$916K 0.38%
40,250
ACAD icon
29
Acadia Pharmaceuticals
ACAD
$5.02B
$863K 0.36%
30,947
-24,000
-44% -$715K
T icon
30
AT&T
T
$178B
$832K 0.35%
29,194
+26,480
+976% +$781K
FF icon
31
Future Fuel
FF
$234M
$827K 0.35%
54,804
VZ icon
32
Verizon
VZ
$208B
$818K 0.34%
18,311
+16,728
+1,057% +$779K
APO icon
33
Apollo Global Management
APO
$79.7B
$794K 0.33%
+30,000
New +$799K
RHP icon
34
Ryman Hospitality Properties
RHP
$8.92B
$794K 0.33%
12,400
+12,000
+3,000% +$765K
GE icon
35
GE Aerospace
GE
$355B
$775K 0.32%
5,984
+5,007
+512% +$686K
GILD icon
36
Gilead Sciences
GILD
$181B
$738K 0.31%
10,420
+3,700
+55% +$246K
SVC
37
Service Properties Trust
SVC
$1.02B
$729K 0.3%
5,000
+4,800
+2,400% +$733K
SGYP
38
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$705K 0.29%
158,400
WHLRD
39
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$64.9M
$692K 0.29%
30,000
XRN
40
Chiron Real Estate Inc
XRN
$487M
$688K 0.29%
15,400
WY icon
41
Weyerhaeuser
WY
$17B
$670K 0.28%
+20,000
New +$673K
IBM icon
42
IBM
IBM
$222B
$659K 0.28%
4,481
CORV
43
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$608K 0.25%
134,578
+58,278
+76% +$211K
SBCP
44
DELISTED
Sunshine Bancorp, Inc
SBCP
$593K 0.25%
27,800
IMMU
45
DELISTED
Immunomedics Inc
IMMU
$581K 0.24%
65,783
+20,283
+45% +$142K
EW icon
46
Edwards Lifesciences
EW
$52B
$578K 0.24%
+14,673
New +$536K
DERM
47
DELISTED
Dermira, Inc.
DERM
$537K 0.22%
+18,431
New +$560K
CDOR
48
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$535K 0.22%
50,000
CHEKW
49
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$495K 0.21%
66,059
IRT icon
50
Independence Realty Trust
IRT
$3.84B
$494K 0.21%
50,000

Similar funds

David M. Knott's Q2 2017 Portfolio in Review

As of Q2 2017, David M. Knott held 94 positions worth $240M, up 15% from $208M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

David M. Knott deployed $17.7M of net new capital in Q2 2017, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Howard Hughes: 15,735 shares worth $1.84M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 75% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Acadia Pharmaceuticals, an estimated $715K trimmed.

  • David M. Knott's largest Q2 2017 buy was Howard Hughes: 15,735 shares worth $1.84M.
  • David M. Knott added most to Pfizer in Q2 2017, an estimated $2.06M increase.
  • David M. Knott's biggest Q2 2017 reduction was Acadia Pharmaceuticals, cutting an estimated $715K.
  • David M. Knott fully exited Atlas Corp. in Q2 2017, selling an estimated $693K.
  • David M. Knott's ten largest holdings make up 80% of its $240M portfolio in Q2 2017.
  • David M. Knott opened 15 new positions and closed 4 in Q2 2017.
  • David M. Knott's portfolio value rose 15% quarter-over-quarter to $240M.

Based on David M. Knott's 13F filing for Q2 2017, filed 11 Aug 2017.